The ophthalmic implications of COVID-19: What we know so far
June 21, 2020
Emerging data on conjunctivitis cases in COVID-19 patients necessitate high levels of caution and a meticulous approach during the pandemic.
© 2020 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
Cornea
Minimising risks during routine ophthalmic examinations in the COVID-19 era
August 24, 2020
Until we have a vaccine and see a reduction of COVID-19 cases down to zero, we must adjust and take every precaution possibly to protect our staff, as well as our patients.
Being the ‘boss’ of the graft
May 04, 2020
Corneal collagen crosslinking imperative in paediatric keratoconus
February 10, 2020
Facing challenge of corneal infection management in operated eyes
October 17, 2019
Early identification, aggressive treatment critical; when to consider surgical intervention
Towards a customised treatment of patients with keratoconic eyes
September 01, 2019
Immune mechanisms in allergic eye disease
February 26, 2018
Ocular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.
Cellular therapy of the corneal stroma: Real approach or science fiction?
January 08, 2018
The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.